Bcl-2 inhibitors are a class of drugs designed to target the B-cell lymphoma 2 (Bcl-2) protein, which is known for its role in preventing apoptosis, or programmed cell death. By inhibiting Bcl-2, these drugs aim to promote the death of cancerous cells, thereby reducing tumor growth.
